Drug Search Results

Fursultiamine

Alternative Names: fursultiamine, adventan
Latest Update: 2024-02-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: ThTR Binder

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Transdermal

FDA Designation: None *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: Fundacion IMIM
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Fursultiamine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Squamous Cell Carcinoma|Esophageal Cancer

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
A-BR-104-105	P2	Completed	Squamous Cell Carcinoma\|Esophageal Cancer	2017-12-01

Recent News Events

Date	Type	Title
02/01/2024	PubMed	Cream versus ointment: Randomized single-blinded study on the adherence to treatment with topical methylprednisolone aceponate.
01/01/2023	PubMed	[A CASE OF ANAPHYLAXIS INDUCED BY VITAMIN B1 DERIVATIVE IN VITAMIN B INFUSION FORMULATION FOR INTRAVENOUS INJECTION].
08/01/2022	PubMed	Fitting Pharmacodynamic Data to the Emax Model to Assess the Inherent Potency of Topical Corticosteroids.
06/20/2019	News Article	Fursultiamine (CAS 804-30-8) Market Research Report 2019 - ResearchAndMarkets.com
06/20/2019	News Article	Global Fursultiamine (CAS 804-30-8) Markets 2019 - Applications, Manufacturing Methods, Patents, Prices, End-Users
06/20/2019	News Article	Global Fursultiamine (CAS 804-30-8) Markets 2019 - Applications, Manufacturing Methods, Patents, Prices, End-Users

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions